Publisher
source

Queen Mary University of London

PhD Studentships in Organ-on-a-Chip Technology, Biomedical Engineering, and Cancer Research at Queen Mary University of London Queen Mary University of London in United Kingdom

Degree Level

PhD

Field of study

Biomedical Engineering

Funding

Full funding available

Deadline

December 31, 2026
Country flag

Country

United Kingdom

University

Queen Mary University of London

Social connections

How do I apply for this?

Sign in for free to reveal details, requirements, and source links.

Where to contact

Keywords

Biomedical Engineering
Biology
Radiation Therapy
Tissue Engineering
Cancer Research
Medical Science
Neurotoxicity
Organ-on-a-chip
Cerebral Organoids
Tumour Progression
Microfluidics
- Neuroscience

About this position

The EPSRC Centre for Doctoral Training (CDT) in Next Generation Organ-on-a-Chip Technology at Queen Mary University of London is now recruiting PhD students for its 2026 cohort. The CDT, based within the Centre for Predictive in vitro Models, offers a multidisciplinary research environment focused on developing advanced in vitro models for biomedical research, disease modeling, and drug discovery. Projects span a range of topics including organ-on-a-chip platforms for liver, kidney, brain, skin, and tumour models, with applications in cancer research, neurotoxicity, radiotherapy, and tissue engineering.

Key research areas include:

  • Developing liver-on-a-chip platforms to assess radiation-induced injury, supervised by Dr Neil Dufton and Prof William Alazawi.
  • Advanced glomerulus-on-a-chip models for kidney inflammation (Dr Maria Fragiadaki, Prof Thomas Iskratsch).
  • 3D printed chips integrating cerebral organoids with electrode arrays for neurotoxicity testing (Dr Isabel Palacios, Prof Julien Gautrot).
  • In vitro models to study tumour progression and bottlenecks (Dr Adrian Biddle, Prof John Marshall).
  • Brain tumour margin-on-a-chip models for studying recurrence and electrotherapies (Dr Christopher Chapman, Dr Agnes Nishimura).
  • Dual-use skin-on-a-chip models for oncology drug toxicity (Prof John Connelly, Dr Daniele Bergamaschi).
  • Industry-sponsored projects, such as the Peptimatrix project led by Prof Martin Knight, focus on testing novel 3D matrix environments within commercial organ-chips.

Students will join a vibrant research community, benefit from state-of-the-art facilities, and collaborate with industry partners including Peptimatrix, AstraZeneca, and Vertex Pharmaceuticals. The programme is fully funded for eligible students, covering tuition and a stipend. Applicants should have a strong background in biomedical engineering, biology, or related fields, and a keen interest in multidisciplinary research. The application deadline is August 1, 2026, for a September 2026 start. For more information and to apply, visit the Centre for Predictive in vitro Models website.

Funding details

Full funding including tuition fees and living expenses is available for this position. The scholarship covers all educational costs and provides a monthly stipend.

How to apply

Please submit your application including a cover letter, CV, academic transcripts, and contact information for two references. Applications should be sent via the online portal before the deadline.

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?

Professors